Published in Ann Cardiothorac Surg on July 01, 2012
Costs of periprocedural complications in patients treated with transcatheter aortic valve replacement: results from the Placement of Aortic Transcatheter Valve trial. Circ Cardiovasc Interv (2014) 1.49
Model-based economic evaluation for medical decision making: learn from the past and prepare for the future. J Thorac Dis (2013) 0.75
Quality of life among elderly patients undergoing transcatheter or surgical aortic valve replacement- a model-based longitudinal data analysis. Health Qual Life Outcomes (2016) 0.75
Transcatheter Aortic Valve Implantation for Treatment of Aortic Valve Stenosis: A Health Technology Assessment. Ont Health Technol Assess Ser (2016) 0.75
Conceptual model for early health technology assessment of current and novel heart valve interventions. Open Heart (2016) 0.75
Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med (2011) 15.70
Markov models in medical decision making: a practical guide. Med Decis Making (1994) 8.14
Preference-Based EQ-5D index scores for chronic conditions in the United States. Med Decis Making (2006) 3.62
Monitoring clinical changes in patients with heart failure: a comparison of methods. Am Heart J (2005) 3.26
Registry of transcatheter aortic-valve implantation in high-risk patients. N Engl J Med (2012) 2.88
Transcatheter aortic valve implantation: early results of the FRANCE (FRench Aortic National CoreValve and Edwards) registry. Eur Heart J (2010) 2.63
Cost-effectiveness of transcatheter aortic valve replacement compared with surgical aortic valve replacement in high-risk patients with severe aortic stenosis: results of the PARTNER (Placement of Aortic Transcatheter Valves) trial (Cohort A). J Am Coll Cardiol (2012) 2.56
The association of left ventricular ejection fraction, mortality, and cause of death in stable outpatients with heart failure. J Am Coll Cardiol (2003) 2.34
The frequency and cost of complications associated with coronary artery bypass grafting surgery: results from the United States Medicare program. Ann Thorac Surg (2008) 2.29
Impact of residual regurgitation after aortic valve replacement. Eur J Cardiothorac Surg (2012) 2.24
Selection criteria and generalizability within the counterfactual framework: explaining the paradox of antidepressant-induced suicidality? Clin Trials (2009) 2.01
One-year outcomes of cohort 1 in the Edwards SAPIEN Aortic Bioprosthesis European Outcome (SOURCE) registry: the European registry of transcatheter aortic valve implantation using the Edwards SAPIEN valve. Circulation (2011) 1.98
Clinical outcomes of patients with severe aortic stenosis at increased surgical risk according to treatment modality. J Am Coll Cardiol (2011) 1.86
Health-related quality of life after transcatheter aortic valve replacement in inoperable patients with severe aortic stenosis. Circulation (2011) 1.79
Clinical and hemodynamic outcomes of "all-comers" undergoing transapical aortic valve implantation: results from the Italian Registry of Trans-Apical Aortic Valve Implantation (I-TA). J Thorac Cardiovasc Surg (2011) 1.64
Aortic valve replacement: results and predictors of mortality from a contemporary series of 2256 patients. J Thorac Cardiovasc Surg (2010) 1.64
One year follow-up of the multi-centre European PARTNER transcatheter heart valve study. Eur Heart J (2010) 1.63
Aortic valve replacement in octogenarians: utility of risk stratification with EuroSCORE. Ann Thorac Surg (2009) 1.32
Long-term costs and resource use in elderly participants with congestive heart failure in the Cardiovascular Health Study. Am Heart J (2007) 1.29
Transapical aortic valve implantation: analysis of risk factors and learning experience in 299 patients. Circulation (2011) 1.28
High-risk aortic valve replacement: are the outcomes as bad as predicted? Ann Thorac Surg (2008) 1.27
Prognosis after aortic valve replacement with a bioprosthesis: predictions based on meta-analysis and microsimulation. Circulation (2001) 1.24
Cost-effectiveness of aortic valve replacement in the elderly: an introductory study. J Thorac Cardiovasc Surg (2007) 1.21
Procedural, 30-day and one year outcome following CoreValve or Edwards transcatheter aortic valve implantation: results of the Belgian national registry. Interact Cardiovasc Thorac Surg (2011) 1.17
Long-term cost of stroke subtypes among Medicare beneficiaries. Cerebrovasc Dis (2006) 1.14
Outcomes of surgical aortic valve replacement in high-risk patients: a multiinstitutional study. Ann Thorac Surg (2011) 1.14
Long-term performance of heart valve prostheses. Curr Probl Cardiol (2000) 1.13
Health-related quality of life after stroke a comprehensive review. Stroke (2001) 1.12
Twenty-year comparison of tissue and mechanical valve replacement. J Thorac Cardiovasc Surg (2001) 1.12
Clinical outcome and predictors for adverse events after transcatheter aortic valve implantation with the use of different devices and access routes. Am Heart J (2011) 1.12
Community-based stroke incidence in a Scottish population: the Scottish Borders Stroke Study. Stroke (2005) 1.10
Outcomes after transcatheter aortic valve implantation: transfemoral versus transapical approach. Ann Thorac Surg (2011) 1.00
Utilities should not be multiplied: evidence from the preference-based scores in the United States. Med Care (2008) 1.00
Transapical aortic valve implantation at 3 years. J Thorac Cardiovasc Surg (2011) 0.93
Society of Thoracic Surgeons score is superior to the EuroSCORE determining mortality in high risk patients undergoing isolated aortic valve replacement. Ann Thorac Surg (2009) 0.93
Patient-prosthesis mismatch after transapical aortic valve implantation: incidence and impact on survival. J Thorac Cardiovasc Surg (2012) 0.90
Risk profile and outcomes of aortic valve replacement in octogenarians. World J Cardiol (2011) 0.89
The European System for Cardiac Operative Risk Evaluation (EuroSCORE) is not appropriate for withholding surgery in high-risk patients with aortic stenosis: a retrospective cohort study. J Cardiothorac Surg (2009) 0.89
Analysis of survival in 300 high-risk patients up to 2.5 years after transapical aortic valve implantation. Ann Thorac Surg (2011) 0.89
Assessing the validity of clinical trials. J Pediatr Gastroenterol Nutr (2008) 0.87
Transapical aortic valve implantation in Rouen: four years' experience with the Edwards transcatheter prosthesis. Arch Cardiovasc Dis (2012) 0.83
Contemporary results for isolated aortic valve surgery. Thorac Cardiovasc Surg (2011) 0.83
Long-term consequences of postoperative heart failure after surgery for aortic stenosis compared with coronary surgery. Ann Thorac Surg (2007) 0.80
The prognostic value of a nomogram for exercise capacity in women. N Engl J Med (2005) 5.03
Left ventricular dyssynchrony predicts response and prognosis after cardiac resynchronization therapy. J Am Coll Cardiol (2004) 3.87
Diabetic cardiomyopathy: evidence, mechanisms, and therapeutic implications. Endocr Rev (2004) 3.69
Tissue Doppler imaging a new prognosticator for cardiovascular diseases. J Am Coll Cardiol (2007) 3.41
Independent and incremental role of quantitative right ventricular evaluation for the prediction of right ventricular failure after left ventricular assist device implantation. J Am Coll Cardiol (2012) 3.17
Prediction of all-cause mortality from global longitudinal speckle strain: comparison with ejection fraction and wall motion scoring. Circ Cardiovasc Imaging (2009) 3.06
Exercise training for patients with heart failure: a systematic review of factors that improve mortality and morbidity. Am J Med (2004) 2.81
Global 2-dimensional strain as a new prognosticator in patients with heart failure. J Am Coll Cardiol (2009) 2.77
Patients with early diabetic heart disease demonstrate a normal myocardial response to dobutamine. J Am Coll Cardiol (2003) 2.76
EAE/ASE recommendations for image acquisition and display using three-dimensional echocardiography. J Am Soc Echocardiogr (2012) 2.41
Alterations of left ventricular myocardial characteristics associated with obesity. Circulation (2004) 2.41
The relative importance of vascular structure and function in predicting cardiovascular events. J Am Coll Cardiol (2004) 2.32
Effect of If-channel inhibition on hemodynamic status and exercise tolerance in heart failure with preserved ejection fraction: a randomized trial. J Am Coll Cardiol (2013) 2.24
Reproducibility and accuracy of echocardiographic measurements of left ventricular parameters using real-time three-dimensional echocardiography. J Am Coll Cardiol (2004) 2.21
Normal ranges of left ventricular strain: a meta-analysis. J Am Soc Echocardiogr (2012) 2.17
Percutaneous coronary intervention in patients with severe aortic stenosis: implications for transcatheter aortic valve replacement. Circulation (2012) 2.17
Exercise testing in asymptomatic patients after revascularization: are outcomes altered? Arch Intern Med (2012) 2.10
Left ventricular dyssynchrony predicts benefit of cardiac resynchronization therapy in patients with end-stage heart failure before pacemaker implantation. Am J Cardiol (2003) 2.08
Reproducibility of echocardiographic techniques for sequential assessment of left ventricular ejection fraction and volumes: application to patients undergoing cancer chemotherapy. J Am Coll Cardiol (2012) 2.07
Exercise training for type 2 diabetes mellitus: impact on cardiovascular risk: a scientific statement from the American Heart Association. Circulation (2009) 2.06
Association of subclinical right ventricular dysfunction with obesity. J Am Coll Cardiol (2006) 1.81
Real-time 3D echocardiographic quantification of left atrial volume: multicenter study for validation with CMR. JACC Cardiovasc Imaging (2012) 1.74
Prediction of hospital outcome in septic shock: a prospective comparison of tissue Doppler and cardiac biomarkers. Crit Care (2010) 1.73
Association of imaging markers of myocardial fibrosis with metabolic and functional disturbances in early diabetic cardiomyopathy. Circ Cardiovasc Imaging (2011) 1.73
Prevalence of heart failure and systolic ventricular dysfunction in older Australians: the Canberra Heart Study. Med J Aust (2006) 1.72
A gatekeeper for the gatekeeper: inappropriate referrals to stress echocardiography. Am Heart J (2007) 1.71
Cardioprotective effect of β-adrenoceptor blockade in patients with breast cancer undergoing chemotherapy: follow-up study of heart failure. Circ Heart Fail (2013) 1.70
Relationship of ventricular longitudinal function to contractile reserve in patients with mitral regurgitation. Am Heart J (2003) 1.69
Impact of gender on risk stratification by exercise and dobutamine stress echocardiography: long-term mortality in 4234 women and 6898 men. Eur Heart J (2005) 1.68
Evidence for abnormal left ventricular structure and function in normotensive individuals with familial hyperaldosteronism type I. J Clin Endocrinol Metab (2005) 1.68
Why all the focus on cardiac imaging? JACC Cardiovasc Imaging (2010) 1.68
Echocardiographic detection of early diabetic myocardial disease. J Am Coll Cardiol (2003) 1.65
A randomized study of the beneficial effects of aldosterone antagonism on LV function, structure, and fibrosis markers in metabolic syndrome. JACC Cardiovasc Imaging (2011) 1.65
Effect of statin therapy on the risk for incident heart failure in patients with breast cancer receiving anthracycline chemotherapy: an observational clinical cohort study. J Am Coll Cardiol (2012) 1.65
Tissue Doppler in critical illness: a retrospective cohort study. Crit Care (2007) 1.65
Cardiac dimensions are largely determined by dietary salt in patients with primary aldosteronism: results of a case-control study. J Clin Endocrinol Metab (2011) 1.64
Association of cardiac autonomic neuropathy with subclinical myocardial dysfunction in type 2 diabetes. JACC Cardiovasc Imaging (2010) 1.62
Contribution of exercise echocardiography to the diagnosis of heart failure with preserved ejection fraction (HFpEF). Heart (2010) 1.60
Independent association of left atrial function with exercise capacity in patients with preserved ejection fraction. Heart (2012) 1.58
Identification of therapeutic benefit from revascularization in patients with left ventricular systolic dysfunction: inducible ischemia versus hibernating myocardium. Circ Cardiovasc Imaging (2013) 1.58
Effect of aldosterone antagonism on myocardial dysfunction in hypertensive patients with diastolic heart failure. Circulation (2004) 1.57
Diastolic stress echocardiography: hemodynamic validation and clinical significance of estimation of ventricular filling pressure with exercise. J Am Coll Cardiol (2006) 1.57
Randomized trial of guiding hypertension management using central aortic blood pressure compared with best-practice care: principal findings of the BP GUIDE study. Hypertension (2013) 1.56
Impact of aortic valve replacement on outcome of symptomatic patients with severe aortic stenosis with low gradient and preserved left ventricular ejection fraction. Circulation (2013) 1.51
Incremental cost-effectiveness of exercise echocardiography vs. SPECT imaging for the evaluation of stable chest pain. Eur Heart J (2006) 1.51
Patients with a hypertensive response to exercise have impaired systolic function without diastolic dysfunction or left ventricular hypertrophy. J Am Coll Cardiol (2004) 1.50
Association of masked hypertension and left ventricular remodeling with the hypertensive response to exercise. Am J Hypertens (2011) 1.50
Prognostic implications of left ventricular filling pressure with exercise. Circ Cardiovasc Imaging (2010) 1.47
Complementary and alternative medicine use in rheumatoid arthritis: an audit of patients visiting a tertiary care centre. Natl Med J India (2008) 1.45
QT interval variability in type 2 diabetic patients with cardiac sympathetic dysinnervation assessed by 123I-metaiodobenzylguanidine scintigraphy. J Cardiovasc Electrophysiol (2012) 1.41
Is 'diastolic heart failure' a diagnosis of exclusion? Echocardiographic parameters of diastolic dysfunction in patients with heart failure and normal systolic function. Heart Lung Circ (2003) 1.41
Comparative prediction of cardiac events by wall motion, wall motion plus coronary flow reserve, or myocardial perfusion analysis: a multicenter study of contrast stress echocardiography. JACC Cardiovasc Imaging (2012) 1.41
Use of myocardial deformation imaging to detect preclinical myocardial dysfunction before conventional measures in patients undergoing breast cancer treatment with trastuzumab. Am Heart J (2009) 1.41
Feasibility and accuracy of different techniques of two-dimensional speckle based strain and validation with harmonic phase magnetic resonance imaging. J Am Soc Echocardiogr (2008) 1.40
Comparison of two-dimensional speckle and tissue velocity based strain and validation with harmonic phase magnetic resonance imaging. Am J Cardiol (2006) 1.40
Cardiogenic shock in the setting of severe aortic stenosis: role of intra-aortic balloon pump support. Heart (2010) 1.40
Effects of perhexiline on myocardial deformation in patients with ischaemic left ventricular dysfunction. Int J Cardiol (2009) 1.40
Validation of a generalized transfer function to noninvasively derive central blood pressure during exercise. Hypertension (2006) 1.40
Patients with coronary slow flow phenomenon demonstrate normal myocardial blood flow and arterial wave reflection between acute episodes. Int J Cardiol (2008) 1.39
Relationship between longitudinal and radial contractility in subclinical diabetic heart disease. Clin Sci (Lond) (2004) 1.37
Atherosclerotic disease is increased in recent-onset rheumatoid arthritis: a critical role for inflammation. Arthritis Res Ther (2007) 1.37
Differentiation of subendocardial and transmural infarction using two-dimensional strain rate imaging to assess short-axis and long-axis myocardial function. J Am Coll Cardiol (2006) 1.36
Obesity cardiomyopathy: pathogenesis and pathophysiology. Nat Clin Pract Cardiovasc Med (2007) 1.34
EAE/ASE recommendations for image acquisition and display using three-dimensional echocardiography. Eur Heart J Cardiovasc Imaging (2012) 1.33
Assessment of nonischemic myocardial fibrosis. J Am Coll Cardiol (2010) 1.32
Impact of home versus clinic-based management of chronic heart failure: the WHICH? (Which Heart Failure Intervention Is Most Cost-Effective & Consumer Friendly in Reducing Hospital Care) multicenter, randomized trial. J Am Coll Cardiol (2012) 1.31
Left ventricular volume measurement with echocardiography: a comparison of left ventricular opacification, three-dimensional echocardiography, or both with magnetic resonance imaging. Eur Heart J (2008) 1.28
Determinants of exercise capacity in patients with type 2 diabetes. Diabetes Care (2005) 1.28
Comparison of two-dimensional speckle and tissue Doppler strain measurement during dobutamine stress echocardiography: an angiographic correlation. Eur Heart J (2007) 1.25
Myocardial and vascular dysfunction and exercise capacity in the metabolic syndrome. Am J Cardiol (2005) 1.24
Accuracy and feasibility of online 3-dimensional echocardiography for measurement of left ventricular parameters. J Am Soc Echocardiogr (2006) 1.24
Bariatric surgery and cardiovascular outcomes: a systematic review. Heart (2012) 1.24
What is the optimal clinical technique for measurement of left ventricular volume after myocardial infarction? A comparative study of 3-dimensional echocardiography, single photon emission computed tomography, and cardiac magnetic resonance imaging. J Am Soc Echocardiogr (2006) 1.22
Screening for heart disease in diabetic subjects. Am Heart J (2005) 1.22
Exercise training in systolic and diastolic dysfunction: effects on cardiac function, functional capacity, and quality of life. Am Heart J (2007) 1.22
Independent and incremental value of deformation indices for prediction of trastuzumab-induced cardiotoxicity. J Am Soc Echocardiogr (2013) 1.19
Effects of treatment on exercise tolerance, cardiac function, and mortality in heart failure with preserved ejection fraction. A meta-analysis. J Am Coll Cardiol (2011) 1.17
Comparison of two- and three-dimensional echocardiography with sequential magnetic resonance imaging for evaluating left ventricular volume and ejection fraction over time in patients with healed myocardial infarction. Am J Cardiol (2006) 1.17
Assessment of diastolic function: what the general cardiologist needs to know. Heart (2005) 1.17
Role of cardioprotective therapy for prevention of cardiotoxicity with chemotherapy: a systematic review and meta-analysis. Eur J Cancer (2013) 1.13
Increased targeting of cardiovascular risk factors in patients with chronic kidney disease does not improve atheroma burden or cardiovascular function. Am Heart J (2006) 1.12
Fibrosis and cardiac function in obesity: a randomised controlled trial of aldosterone blockade. Heart (2013) 1.09
Sleep quality and health-related quality of life in idiopathic pulmonary fibrosis. Chest (2008) 1.09
Dyspnea and risk in suspected coronary disease. N Engl J Med (2005) 1.09
Assessment of myocardial viability at dobutamine echocardiography by deformation analysis using tissue velocity and speckle-tracking. JACC Cardiovasc Imaging (2010) 1.08
Incremental value of strain rate analysis as an adjunct to wall-motion scoring for assessment of myocardial viability by dobutamine echocardiography: a follow-up study after revascularization. Circulation (2005) 1.08
Exercise-induced hypertension, cardiovascular events, and mortality in patients undergoing exercise stress testing: a systematic review and meta-analysis. Am J Hypertens (2012) 1.08
Use of myocardial strain to assess global left ventricular function: a comparison with cardiac magnetic resonance and 3-dimensional echocardiography. Am Heart J (2009) 1.08
Assessment of left atrial mechanics in patients with atrial fibrillation: comparison between two-dimensional speckle-based strain and velocity vector imaging. J Am Soc Echocardiogr (2012) 1.08
Association of myocardial deformation with outcome in asymptomatic aortic stenosis with normal ejection fraction. Circ Cardiovasc Imaging (2012) 1.08
Ischaemia and outcome with normal coronary arteries. Eur Heart J (2005) 1.07
Automated analysis of myocardial deformation at dobutamine stress echocardiography: an angiographic validation. J Am Coll Cardiol (2007) 1.07
Clinical assessment of left ventricular systolic torsion: effects of myocardial infarction and ischemia. J Am Soc Echocardiogr (2008) 1.06
Clinical utility of multimodality LA imaging: assessment of size, function, and structure. JACC Cardiovasc Imaging (2011) 1.06
Use and Limitations of E/e' to Assess Left Ventricular Filling Pressure by Echocardiography. J Cardiovasc Ultrasound (2011) 1.05
Incremental benefit of myocardial contrast to combined dipyridamole-exercise stress echocardiography for the assessment of coronary artery disease. Circulation (2004) 1.04
Use of real-time three-dimensional echocardiography to measure left atrial volume: comparison with other echocardiographic techniques. J Am Soc Echocardiogr (2005) 1.04